Lpl Financial LLC P Lx Pharma Inc. Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.15 - $0.63 $1,446 - $6,073	-9,640 Reduced 31.71%	20,760 $3,000
Q3 2022 Nov 14, 2022	SELL	$0.52 - $3.08 $13,000 - $77,000	-25,000 Reduced 45.13%	30,400 $20,000
Q2 2022 Aug 12, 2022	SELL	$1.9 - $4.18 $9,500 - $20,900	-5,000 Reduced 8.28%	55,400 $135,000
Q1 2022 May 16, 2022	SELL	$3.54 - $8.3 $531 - $1,245	-150 Reduced 0.25%	60,400 $244,000
Q4 2021 Feb 14, 2022	BUY	$7.69 - $19.66 $465,629 - $1.19 Million	60,550 New	60,550 $485,000

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.